We are live on
!
Find out more
CCS
Crosspoint Capital Strategies Portfolio holdings
AUM
$50.4M
1-Year Est. Return
15.37%
This Fund
S&P 500
This Quarter
Est. Return
+20.36%
1 Year Est. Return
-15.37%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$300M
AUM Growth
–
Cap. Flow
+$255M
Cap. Flow
% of AUM
85.02%
Top 10 Holdings %
Top 10 Hldgs %
21.15%
Holding
578
New
578
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$18.4M |
| 2 |
Dorchester Minerals
DMLP
|
+$6.07M |
| 3 |
Apple
AAPL
|
+$5.22M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
+$4.76M |
| 5 |
MHR
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
|
+$4.63M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.17% |
| 2 | Healthcare | 18.72% |
| 3 | Communication Services | 13.88% |
| 4 | Industrials | 11.7% |
| 5 | Energy | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Kulicke & Soffa
KLIC
$4.43B
| $508K | 0.17% |
+44,385
| New | +$557K |
|
|
CRT
102
Cross Timbers Royalty Trust
CRT
$63.1M
| $507K | 0.17% |
+16,885
| New | +$499K |
|
103
AT&T
T
$174B
| $455K | 0.15% |
+18,733
| New | +$493K |
|
104
Chevron
CVX
$392B
| $438K | 0.15% |
+3,800
| New | +$459K |
|
105
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
| $431K | 0.14% |
+3,691
| New | +$421K |
|
106
Teradata
TDC
$2.65B
| $425K | 0.14% |
+9,182
| New | +$416K |
|
107
Johnson & Johnson
JNJ
$642B
| $399K | 0.13% |
+4,274
| New | +$394K |
|
108
Merck
MRK
$369B
| $355K | 0.12% |
+6,522
| New | +$298K |
|
109
Starwood Property Trust
STWD
$5.89B
| $345K | 0.11% |
+17,749
| New | +$376K |
|
110
IBM
IBM
$225B
| $340K | 0.11% |
+1,908
| New | +$329K |
|
|
TFCF
111
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $331K | 0.11% |
+10,115
| New | +$337K |
|
112
American Airlines Group
AAL
$9.08B
| $326K | 0.11% |
+8,735
| New | +$225K |
|
113
Gilead Sciences
GILD
$185B
| $325K | 0.11% |
+3,915
| New | +$273K |
|
114
GSK
GSK
$101B
| $305K | 0.1% |
+4,326
| New | +$281K |
|
115
Microchip Technology
MCHP
$40.9B
| $299K | 0.1% |
+12,916
| New | +$271K |
|
116
Procter & Gamble
PG
$333B
| $296K | 0.1% |
+3,778
| New | +$308K |
|
117
Macy's
M
$5.92B
| $281K | 0.09% |
+4,867
| New | +$236K |
|
118
Vanguard FTSE Emerging Markets ETF
VWO
$127B
| $280K | 0.09% |
+7,211
| New | +$297K |
|
119
Abbott
ABT
$193B
| $276K | 0.09% |
+6,879
| New | +$254K |
|
120
SPDR Gold Trust
GLD
$154B
| $267K | 0.09% |
+2,078
| New | +$255K |
|
121
Cisco
CSCO
$442B
| $263K | 0.09% |
+12,068
| New | +$267K |
|
|
MMP
122
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $255K | 0.08% |
+3,707
| New | +$221K |
|
123
Public Storage
PSA
$58.1B
| $250K | 0.08% |
+1,463
| New | +$234K |
|
|
DD
124
DELISTED
Du Pont De Nemours E I
DD
| $248K | 0.08% |
+3,876
| New | +$224K |
|
125
Coca-Cola
KO
$384B
| $245K | 0.08% |
+6,393
| New | +$252K |
|
Similar funds
ACM
SJIA
NRC
DFAM
AI
HJMC
HA
JI
Crosspoint Capital Strategies's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Crosspoint Capital Strategies, which disclosed 578 positions worth $300M. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Manhattan Associates: 670,708 shares worth $6.53M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, followed by Healthcare and Communication Services.
- Crosspoint Capital Strategies's largest Q4 2013 buy was Manhattan Associates: 670,708 shares worth $6.53M.
- Crosspoint Capital Strategies's ten largest holdings make up 21% of its $300M portfolio in Q4 2013.
- Crosspoint Capital Strategies disclosed 578 positions in Q4 2013, its first 13F filing on record.
Based on Crosspoint Capital Strategies's 13F filing for Q4 2013, filed 6 Mar 2014.